APA (7th ed.) Citation

S, G., A, S., I, G., S, P., P, M., G, S., . . . RS, S. (2022). Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients. Inflammopharmacology, 30(5), 1843. https://doi.org/10.1007/s10787-022-01049-0

Chicago Style (17th ed.) Citation

S, Goyal, Sood A, Gautam I, Pradhan S, Mondal P, Singh G, Jaura RS, Singh TG, and Sibia RS. "Serum Protease-activated Receptor (PAR-1) Levels as a Potential Biomarker for Diagnosis of Inflammation in Type 2 Diabetic Patients." Inflammopharmacology 30, no. 5 (2022): 1843. https://doi.org/10.1007/s10787-022-01049-0.

MLA (9th ed.) Citation

S, Goyal, et al. "Serum Protease-activated Receptor (PAR-1) Levels as a Potential Biomarker for Diagnosis of Inflammation in Type 2 Diabetic Patients." Inflammopharmacology, vol. 30, no. 5, 2022, p. 1843, https://doi.org/10.1007/s10787-022-01049-0.